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Purpose: To understand the relationship between lactate accumulation in the
blood during exercise and subjective measures of fatigue in cancer patients after
a 12-week exercise intervention. Hypothesis: Exercise training will delay the
onset of blood lactate accumulation (OBLA) during progressive exercise and this
will be associated with a decrease in subjective perceptions of fatigue at rest.
Methods: Participants were recruited upon referral by a physician to the UNCCRI
Phase Program. Each participant performed an exercise-based assessment upon
entry which included measures of fatigue and cardiorespiratory fitness (CRF).
CRF was assessed using the UNCCRI treadmill protocol and blood lactate
measurements were obtained every 2 minutes during this progressive exercise
test. After the 12-week exercise intervention, all measures were repeated.
Markers of performance such as the OBLA and the metabolic equivalent (MET) at
OBLA were used in a correlation analysis with Piper Fatigue Scale scores.
Results: After 12 weeks of exercise, participants showed a significant decrease
in total fatigue (pre: 4.09 ± 1.78, post: 3.12 ±1.93, p < 0.01), behavioral fatigue
(pre: 3.83 ± 2.46, post: 2.39 ± 2.22, p < 0.01), affective fatigue (pre: 4.25 ±
2.32, post: 3.43 ± 2.26, p < 0.05), sensory fatigue (pre: 4.71 ± 1.86, post: 3.49
± 2.01, p < 0.001), and cognitive fatigue (pre: 3.88 ± 1.76, post: 3.17 ± 1.82, p
< 0.05). After the intervention, participants showed a significant increase in MET
at OBLA (pre: 5.76 ± 1.73, post: 6.91 ± 1.83, p < 0.001), time to termination of
the treadmill protocol (pre: 8.76 ± 3.09, post: 9.92 ± 3.07 minutes, p < 0.001),
MET at completion (pre: 5.9 ± 2.04, post: 6.78 ± 2.2, p < 0.001), and lactate
concentration at the time of termination (pre: 5.65 ± 2.28, post: 6.63 ± 3.07
mmol, p < 0.05). Correlating MET at OBLA at the initial assessment with initial
measures of fatigue showed a weak, negative correlation with all fatigue
measures (total fatigue: r = - 0.21, behavioral fatigue: r = - 0.17, affective fatigue: r
= - 0.25, sensory fatigue: r = - 0.16, cognitive fatigue: r = - 0.08). After 12 weeks of
exercise, correlating MET at OBLA with follow-up fatigue measures showed
improved correlation to all measure of fatigue except affective fatigue (total
fatigue: r = - 0.22, behavioral fatigue: r = - 0.25, affective fatigue: r = - 0.17,
sensory fatigue: r = - 0.18, cognitive fatigue: r = - 0.10). None of the correlation
coefficients were statistically significant. Conclusion: These data indicate a weak
relationship between OBLA and perception of fatigue. The lack of a significant
correlation for any measure of fatigue and OBLA does not support the initial
hypothesis. In turn, these data provide no strong evidence for a relationship
between exercise OBLA and perception of fatigue at rest in a population of cancer
patients after 12 weeks of exercise training.
• These data indicate a weak relationship between OBLA and perception
of fatigue.
• These data provide no strong evidence for a relationship between
exercise OBLA and perception of fatigue at rest in a population of
cancer patients after 12 weeks of exercise training.
Participants were recruited upon referral by a physician to the UNCCRI
Phase Program. Each participant performed an exercise-based
assessment upon entry which included measures of fatigue and CRF.
CRF was assessed using the UNCCRI treadmill protocol and blood
lactate measurements were obtained every 2 minutes during this
progressive exercise test. After the 12-week exercise intervention, all
measures were repeated. Markers of performance such as the OBLA
and the MET at OBLA were used in a correlation analysis with Piper
Fatigue Scale scores.
After 12 weeks of exercise, participants showed a significant decrease in
total fatigue (pre: 4.09 ± 1.78, post: 3.12 ±1.9, p < 0.01), behavioral
fatigue (pre: 3.83 ± 2.46, post: 2.39 ± 2.22, p < 0.01), affective fatigue
(pre: 4.25 ± 2.32, post: 3.43 ± 2.26, p < 0.05), sensory fatigue (pre: 4.7
± 1.86, post: 3.49± 2.01, p < 0.001), and cognitive fatigue (pre: 3.88±
1.76, post: 3.17 ± 1.82, p < 0.05). After the intervention, participants
showed a significant increase in MET at OBLA (pre: 5.76 ± 1.73, post:
6.91± 1.83, p < 0.001), time to termination of the treadmill protocol (pre:
8.76 ± 3.09, post: 9.92 ± 3.07 minutes, p < 0.001), MET at completion
(pre: 5.9 ± 2.04, post: 6.78 ± 2.2, p < 0.001), and lactate concentration
at the time of termination (pre: 5.65± 2.28, post: 6.63± 3.07 mmol, p <
0.05). Correlating MET at OBLA at the initial assessment with initial
measures of fatigue showed a weak, negative correlation with all fatigue
measures (total fatigue: r = - 0.21, behavioral fatigue: r = - 0.17, affective
fatigue: r = - 0.25, sensory fatigue: r = - 0.16, cognitive fatigue: r = - 0.08).
After 12 weeks of exercise, correlating MET at OBLA with follow-up
fatigue measures showed improved correlation to all measure of fatigue
except affective fatigue (total fatigue: r = - 0.22, behavioral fatigue: r = -
0.25, affective fatigue: r = - 0.17, sensory fatigue: r = - 0.18, cognitive
fatigue: r = - 0.10). None of the correlation coefficients were statistically
significant.









Total 4.09 ± 1.78 3.12 ± 1.93* - 0.21 - 0.22 
Behavioral 3.38 ± 2.46 2.39 ± 2.22* - 0.17 - 0.25
Affective 4.25 ± 2.32 3.43 ± 2.26* - 0.25 - 0.17
Sensory 4.71 ± 1.83 3.49 ± 2.01* - 0.16 - 0.18
Cognitive 3.88 ± 1.76 3.17 ± 1.82* - 0.08 - 0.10
Values represent sample mean (± standard deviation) of the given population. * Denotes 
significance from initial to post-intervention values within the subject population at alpha = 
0.05 (p < 0.05). 
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Figure 2 Time at Termination and Lactate at Time of Termination. Denotes
significance from pre to post-intervention values within the subject
population at alpha = 0.05 (p < 0.05).
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Figure 1  METS at OBLA and METs at Completion. *Denotes significance from 
pre to post-intervention values within the subject population at alpha = 0.05 (p 
< 0.05).
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